Risultati di ricerca
30 mag 2024 · Alembic Pharmaceuticals Ltd shares gained nearly 3% on Thursday after the company announced receiving final approval from the United States Food and Drug Administration (USFDA) for Sacubitril and Valsartan tablets.
22 ore fa · Alembic Pharmaceuticals Limited announced that Mr. Chandrahas Shetty, President-Human Resources , is superannuating from the said position. Date of cessation & term of appointment: 7th June, 2024... c187d6636c31cc9530c3.U1OAzVITVCn1k-GavjSUJNqLNTBXd_ivTXJU6sxyiUA.FBb1gDQjO1ym-6jxjH3XSqvNV1keOKrJeBY8p-E_sQtmNsuGKlc3e8Cq0Q
16 mag 2024 · Amin said Alembic is targeting R&D spending of ₹550-₹600 crore in FY25, primarily for developing a pipeline of products for the US market, largely consisting of complex formulations such as injectables, ophthalmic, oncology, inhalation, and dermatology products.
- Viswanath Pilla
1 giorno fa · Alembic Pharmaceuticals Limited ha annunciato che il signor Chandrahas Shetty, Presidente delle Risorse Umane , si dimette dall'incarico. Data di cessazione e durata della nomina: 7 giugno 2024 dopo...
30 mag 2024 · Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API).
- (13)
- ALEMBIC PHARMACEUTICALS LIMITED
3 giorni fa · Latest Alembic Ltd (ALEMBICLTD:NSI) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
10 mag 2024 · Alembic Pharmaceuticals' latest earnings report, released on Thursday, highlights an uptick in key financial metrics. The pharma company witnessed an 8% year-on-year increase in net sales, soaring to ₹1,517 crore for the quarter ending March 2024.
